Among them, the RALA c.G482A somatic variant we identified has been reported to be associated with adult T-cell lymphoma leukemia (Kataoka, 2015) and malignant melanoma (Hayward et al., 2017; Wilmott et al., 2019), and no studies have been performed to associate them with neurological diseases. This evidence concerns the gene RALA and melanoma.